Episode 41: DTT is Not a Permanent Residence: Mapping the Real Middle Ground of Structure vs. Autonomy

Episode 41: DTT is Not a Permanent Residence: Mapping the Real Middle Ground of Structure vs. Autonomy

Are we using clinical structure to build real-world independence, or are we just using it as an excuse for corporate and intellectual laziness? This week, Sean and Mike step right into the crossfire of the industry’s loudest, most polarizing argument to map out the definitive middle ground on Discrete Trial Training (DTT). Depending on who you ask on social media, DTT is either the only way to successfully teach complex skills or it’s the absolute poster child for everything wrong with modern, compliance-driven therapy. Both sides are completely right about the execution failures, but they are completely wrong about the science. Sean and Mike strip away the corporate marketing crap, toxic positivity, and traditionalist dogma to expose the reality of engineering behavior that actually leaves the clinical room. They break down: * The Illusion of the Table: Why high acquisition numbers on a tablet can be a clinical lie if the behavior doesn't survive when the theatrical props, cards, and contrived rewards go away. * The Workflow Over Science Trap: Tearing down why clinics stay stubbornly codependent on tabletop drills—not because the science demands it, but because it’s cheap to train, easy to score, and simple to audit for insurance funders. * The True Middle Ground: How to ruthlessly apply intense structural repetition to build prerequisite skills in isolation, while simultaneously programming for prompt fading and Natural Environment Teaching (NET) from day one. * The Generalization Mandate: Why if you cannot describe exactly how a target response transfers across new settings, novel materials, and organic contingencies, you are fundamentally not done designing the clinical program. Stop hiding behind rigid procedural brands or superficial, positive-only marketing labels to avoid the messy, complex work of real-world generalization. DTT should serve as a powerful clinical ladder—but a ladder is meant to be climbed off of, not lived on. Tune in, audit your current setups, and help us reclaim the true spirit of radical behaviorism. Stay bold. Stay contrarian. Stay Rad N Bad.

Episode 40: Who the Hell is Dr. Erin Moran? From Backpacking Kazakhstan to Dismantling Corporate ABA

Most people in the tech space claim they understand the frontline trenches. They haven’t. This week, Sean and Mike pull back the curtain on the corporate contingencies crippling clinical quality, and they are joined by someone who has lived a literal clinical Odyssey: Dr. Erin Moran, Director of Clinical Innovation at Hi-Rasmus. Dr. Moran didn’t just climb a corporate tech ladder. She has been thrown into a room with 38 six-year-olds in a Thai port city with zero support. She has backpacked into the freezing winter of Eastern Kazakhstan with nothing but shorts and a tank top to build parent-led behavior programs from scratch, getting her passport stamped in a dark back alley just to help moms who were told their children's autism was their fault. She has sat on the highly critical academic stages of London as the only BCBA in the room, defending the core science against massive systemic stigma. Sean, Mike, and Erin strip away the marketing fluff and toxic positivity to expose the systemic failures of modern, commercialized operations, including: * The Rebrand Trap: Why the anti-ABA movement isn't attacking our scientific principles, but rather a rigid, high-hour commercialized therapy model that operates like a corporate religion. * The 40-Hour Checkbox Crisis: Tearing down the passive, uninspiring video training models that are producing catastrophic 18% RBT exam pass rates across major national providers, and why real Behavior Skills Training (BST) cannot be scaled through a computer screen. * The Circus Trick of Dependency: Why an intervention that only works when a clinician is standing in the room is a total failure, and how Erin used pure science to train Kazakhstani mothers to become the university professors training the next generation of therapists. * Engineering Software with Science: How Erin is taking her global, boots-on-the-ground experience to design data systems that eliminate administrative headaches, supercharge supervisor feedback loops, and give BCBAs their time back to focus on the work that actually matters. Stop hiding behind empty corporate buzzwords and traditionalist dogma. If your therapy requires rigid compliance and endless paperwork, your environmental engineering is broken. The science doesn’t choose a side—it analyzes contingencies. Tune in to hear how a global perspective is rewriting the status quo of standard industry technology. Stay bold. Stay contrarian. Stay Rad N Bad. https://www.linkedin.com/in/emoran1/

Episode 39: No Man's Land-The Forbidden E-Word: Why You Can’t Escape Extinction

In this episode of the No Man’s Land series, Sean and Mike tackle the 'forbidden E-word' of ABA: Extinction. While cancel culture and critics often paint extinction as cold or outdated, the guys pull the curtain back to show that it’s not a trend—it’s a law of behavior. Whether you call it 'planned ignoring' or 'compassionate support,' if you change a reinforcement contingency, you’re implementing extinction. Sean and Mike dive into the messy reality of extinction bursts, the 'vending machine' analogy of human behavior, and the controversial rise of 'Kind Extinction.' They argue that the science hasn't changed; our clinical skill just finally caught up. Stop avoiding the uncomfortable and start understanding the mechanics of how learning actually happens when the 'house rules' change.

Episode 38: No Man's Land-The Myth of Ascent: Why Choice is Just a Contingency

Is "assent" the future of ethical ABA, or is it a clinical retreat into "fragile tolerance"? In this installment of the No Man’s Land series, Sean Yocum and Mike Carrero step directly into one of the most emotionally charged debates in behavioral health. While the field currently treats assent as an ethical evolution, Sean and Mike strip away the marketing and the buzzwords to look at the raw mechanics underneath. From a radical behaviorist perspective, does "assent" even exist? Or is it simply a hypothetical construct—a label we’ve placed on behavior that is actually being shaped by environmental contingencies? Sean and Mike dive deep into: * The Reality Gap: Are we preparing learners for a world that requires persistence and resilience, or are we engineering "safe spaces" that fail to translate to the real world? * Buzzwords vs. Science: Why "Trauma-Informed Care" and "Assent-Based Care" are often just rebrands for what should have been good behavioral design all along. * The Middle Ground: Moving past the extremes of forced compliance and unlimited refusal to focus on shaping, reinforcement schedules, and functional communication. * The Radical Lens: Reframing refusal not as a philosophical choice, but as critical data that tells us exactly where our behavioral design is failing. Stop asking if your learner "assents" and start asking what your environment is reinforcing. It’s time to move beyond the "feel-good" terminology and get back to the science of shaping independence.

Episode 37: Who the Hell is This? Solving the Access to Care Bottleneck with Amol Deshpande from Frontera Health

The ABA industry has an access problem, and throwing generic corporate software at it isn't fixing a damn thing. In this episode of Rad N Bad, Sean and Mike sit down with Amol Deshpande, the founder of Frontera Health, a Silicon Valley veteran who is injecting radical disruption into the behavioral health tech space. Driven by his personal experience as a parent of an autistic son who achieved a life-changing outcome through high-quality early intervention, Amol isn't here to build another corporate tool. He’s here to dismantle the bottlenecks keeping families stuck on waitlists for months just to get a label. We strip away the marketing crap and dive deep into what it actually takes to scale access to quality care without burning clinicians into the ground. We talk about utilizing advanced, clinician-built AI to obliterate the administrative nightmare of report writing, and why billing platforms do absolutely nothing to change what happens in a child's home on a Tuesday night. Amol pulls no filters as we tackle the toxic tech trends plaguing the sector—specifically software providers who attempt to build a business "moat" by hoarding clinical data and blocking integrations. We unpack the line between clinical augmentation and replacement, why parent-mediated therapy models are the next major frontier, and how passive data collection through video could revolutionize accountability and RBT supervision. Stop letting corporate billing convenience dictate your clinical priorities. It’s time to use technology to eliminate the noise so we can get back to what actually matters: human connection, clinical depth, and radical behavior change. www.fronterahealth.com [www.fronterahealth.com]